Clinical trial

Parkinson's Disease Inflammatory Biomarker Profiling

NCT03633513

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2018-07-10

PhaseN/A

Study timeline

Study start (actual)2018-07-10Date precision: day

Registry last updated2024-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

LBT-3627DIAGNOSTIC_TEST

Immunological profilingDIAGNOSTIC_TEST

Sponsors & collaborators

Longevity Biotechlead sponsor

Michael J. Fox Foundation for Parkinson's Researchcollaborator

Corporal Michael J. Crescenz VA Medical Center - Philadelphiacollaborator

Mapped research locations

PhiladelphiaPennsylvania, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03633513 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.